ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Figure 1Loading Img
ADDITION / CORRECTIONThis article has been corrected. View the notice.

Classics in Chemical Neuroscience: Haloperidol

View Author Information
Chemical Neurobiology Laboratory, Center for Genomic Medicine, Chemical Biology Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, United States
§ Centro de Investigaciones Biológicas-CSIC, Madrid 28040, Spain
*M.W.T. E-mail: [email protected]
*S.J.H. E-mail: [email protected]
Cite this: ACS Chem. Neurosci. 2017, 8, 3, 444–453
Publication Date (Web):February 7, 2017
Copyright © 2017 American Chemical Society

    Article Views





    Other access options


    Abstract Image

    The discovery of haloperidol catalyzed a breakthrough in our understanding of the biochemical basis of schizophrenia, improved the treatment of psychosis, and facilitated deinstitutionalization. In doing so, it solidified the role for chemical neuroscience as a means to elucidate the molecular underpinnings of complex neuropsychiatric disorders. In this Review, we will cover aspects of haloperidol’s synthesis, manufacturing, metabolism, pharmacology, approved and off-label indications, and adverse effects. We will also convey the fascinating history of this classic molecule and the influence that it has had on the evolution of neuropsychopharmacology and neuroscience.

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.


    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Cited By

    This article is cited by 45 publications.

    1. Joshua K. Mitchell, Waseem A. Hussain, Ajay H. Bansode, Ryan M. O’Connor, Dan E. Wise, Michael H. Choe, Marvin Parasram. Photoinduced Nitroarenes as Versatile Anaerobic Oxidants for Accessing Carbonyl and Imine Derivatives. Organic Letters 2023, 25 (35) , 6517-6521.
    2. Anna Schildt, Erik F.J. de Vries, Antoon T.M. Willemsen, Bruno Lima Giacobbo, Rodrigo Moraga-Amaro, Jürgen W.A. Sijbesma, Aren van Waarde, Vesna Sossi, Rudi A.J.O. Dierckx, Janine Doorduin. Effect of Dopamine D2 Receptor Antagonists on [18F]-FEOBV Binding. Molecular Pharmaceutics 2020, 17 (3) , 865-872.
    3. Kilian Colas, A. Catarina V. D. dos Santos, Abraham Mendoza. i-Pr2NMgCl·LiCl Enables the Synthesis of Ketones by Direct Addition of Grignard Reagents to Carboxylate Anions. Organic Letters 2019, 21 (19) , 7908-7913.
    4. Craig W. Lindsley (Editor-in-Chief). Welcome to the DARK Side: DARK Classics in Chemical Neuroscience. ACS Chemical Neuroscience 2018, 9 (10) , 2286-2286.
    5. Julien Lalut, Sofiane Hocine, Gaëtan Maertens, Miguel Vilchis-Reyes, Stephen Hanessian. Design and synthesis of fused azacyclic and azaspirocyclic γ-lactams targeting dopaminergic D2/D4 receptors. Journal of Molecular Structure 2024, 1299 , 137104.
    6. Selen Al, Aykut Kul, Olcay Sagirli. Salt-assisted liquid–liquid microextraction for determination of haloperidol in human plasma by LC-MS/MS. The European Chemistry and Biotechnology Journal 2024, (1) , 39-46.
    7. Samira S. Valvassori, Richard T. da Rosa, Gustavo C. Dal‐Pont, Roger B. Varela, Gustavo A. Mastella, Thiani Daminelli, Gabriel R. Fries, João Quevedo, Alexandra I. Zugno. Haloperidol alters neurotrophic factors and epigenetic parameters in an animal model of schizophrenia induced by ketamine. International Journal of Developmental Neuroscience 2023, 83 (8) , 691-702.
    8. Aline Valéria Sousa Santos, Débora Sterzeck Cardoso, Silvia Honda Takada, Marcela Bermúdez Echeverry. Prenatal exposition to haloperidol: A preclinical narrative review. Neuroscience & Biobehavioral Reviews 2023, 155 , 105470.
    9. Ana Martínez. Dopamine delivery systems based on C 60 and C 24 with B and N as substituents. Canadian Journal of Chemistry 2023, 101 (9) , 595-602.
    10. Mark Makarov, Eduard Korkotian. Differential Role of Active Compounds in Mitophagy and Related Neurodegenerative Diseases. Toxins 2023, 15 (3) , 202.
    11. Jeremy Mills. More than a Half-Century with Haloperidol: Glories, Disparities, and Use Today. Issues in Mental Health Nursing 2023, 44 (1) , 83-87.
    12. Ashley N. Nilson, Daniel E. Felsing, John A. Allen. Dopamine Receptors: Neurotherapeutic Targets for Substance Use Disorders. 2022, 677-731.
    13. King-Chuen Wu, Kai-Sheng Liao, Li-Ren Yeh, Yang-Kao Wang. Drug Repurposing: The Mechanisms and Signaling Pathways of Anti-Cancer Effects of Anesthetics. Biomedicines 2022, 10 (7) , 1589.
    14. Ana Catarina Duarte, Ana Raquel Costa, Isabel Gonçalves, Telma Quintela, Robert Preissner, Cecília R.A. Santos. The druggability of bitter taste receptors for the treatment of neurodegenerative disorders. Biochemical Pharmacology 2022, 197 , 114915.
    15. Kilian Colas, A. Catarina V. D. dos Santos, Stefanie V. Kohlhepp, Abraham Mendoza. Direct Addition of Grignard Reagents to Aliphatic Carboxylic Acids Enabled by Bulky turbo ‐Organomagnesium Anilides. Chemistry – A European Journal 2022, 28 (9)
    16. Jana Osacka, Alexander Kiss, Mojmir Mach, Andrej Tillinger, Romana Koprdova. Haloperidol and aripiprazole affects CRH system and behaviour of animals exposed to chronic mild stress. Neurochemistry International 2022, 152 , 105224.
    17. Han Zhou, Tao Hou, Zhenhua Gao, Xiujie Guo, Chaoran Wang, Jixia Wang, Yanfang Liu, Xinmiao Liang. Discovery of eight alkaloids with D1 and D2 antagonist activity in leaves of Nelumbo nucifera Gaertn. Using FLIPR assays. Journal of Ethnopharmacology 2021, 278 , 114335.
    18. José G. Franco, Gabriel Fernando Oviedo Lugo, Liliana Patarroyo Rodriguez, Jaime Bernal Miranda, Juan Carlos Molano, Monica Rojas Moreno, Carlos Cardeño, Juan David Velasquez Tirado. Encuesta a psiquiatras y residentes de psiquiatría en Colombia sobre sus prácticas preventivas y terapéuticas del delirium. Revista Colombiana de Psiquiatría 2021, 50 (4) , 260-272.
    19. José G. Franco, Gabriel Fernando Oviedo Lugo, Liliana Patarroyo Rodriguez, Jaime Bernal Miranda, Juan Carlos Molano, Monica Rojas Moreno, Carlos Cardeño, Juan David Velasquez Tirado. Survey of psychiatrists and psychiatry residents in Colombia about their preventive and therapeutic practices in delirium. Revista Colombiana de Psiquiatría (English ed.) 2021, 50 (4) , 260-272.
    20. Thiago Garcia Varga, Juan Guilherme de Toledo Simões, Amanda Siena, Elisandra Henrique, Regina Cláudia Barbosa da Silva, Vinicius dos Santos Bioni, Aline Camargo Ramos, Tatiana Rosado Rosenstock. Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats. Psychopharmacology 2021, 238 (9) , 2569-2585.
    21. Hevna Dhulkifle, Abdelali Agouni, Asad Zeidan, Mohammed Saif Al-Kuwari, Aijaz Parray, Mohamed Tolefat, Hesham M. Korashy. Influence of the Aryl Hydrocarbon Receptor Activating Environmental Pollutants on Autism Spectrum Disorder. International Journal of Molecular Sciences 2021, 22 (17) , 9258.
    22. Jana Osacka, Romana Koprdova, Andrej Tillinger, Zdenko Pirnik, Alexander Kiss. Haloperidol and aripiprazole impact on the BDNF and glucocorticoid receptor levels in the rat hippocampus and prefrontal cortex: effect of the chronic mild stress. Endocrine Regulations 2021, 55 (3) , 153-162.
    23. Mingming Dong, Jian-Yu E, Liyang Zhang, Weiyu Teng, Li Tian. Non-ketotic Hyperglycemia Chorea-Ballismus and Intracerebral Hemorrhage: A Case Report and Literature Review. Frontiers in Neuroscience 2021, 15
    24. Jill R. Crittenden, Theresa A. Gipson, Anne C. Smith, Hilary A. Bowden, Ferah Yildirim, Kyle B. Fischer, Michael Yim, David E. Housman, Ann M. Graybiel. Striatal transcriptome changes linked to drug‐induced repetitive behaviors. European Journal of Neuroscience 2021, 53 (8) , 2450-2468.
    25. Anna Wesolowska, Joanna Rychtyk, Joanna Gdula-Argasinska, Katarzyna Gorecka, Natalia Wilczynska-Zawal, Magdalena Jastrzebska-Więsek, Anna Partyka. Effect of 5-HT6 Receptor Ligands Combined with Haloperidol or Risperidone on Antidepressant-/Anxiolytic-Like Behavior and BDNF Regulation in Hippocampus and Prefrontal Cortex of Rats. Neuropsychiatric Disease and Treatment 2021, Volume 17 , 2105-2127.
    26. Gabriela Seabra, Valéria de Almeida, Guilherme Reis-de-Oliveira, Fernanda Crunfli, André Saraiva Leão Marcelo Antunes, Daniel Martins-de-Souza. Ubiquitin–proteasome system, lipid metabolism and DNA damage repair are triggered by antipsychotic medication in human oligodendrocytes: implications in schizophrenia. Scientific Reports 2020, 10 (1)
    27. Guillermo Goode-Romero, Ulrika Winnberg, Laura Domínguez, Ilich A. Ibarra, Rubicelia Vargas, Elisabeth Winnberg, Ana Martínez. New information of dopaminergic agents based on quantum chemistry calculations. Scientific Reports 2020, 10 (1)
    28. Fotios Papadopoulos, Rafaela Isihou, George A. Alexiou, Thomas Tsalios, Evrysthenis Vartholomatos, Georgios S. Markopoulos, Chrissa Sioka, Pericles Tsekeris, Athanasios P. Kyritsis, Vasiliki Galani. Haloperidol Induced Cell Cycle Arrest and Apoptosis in Glioblastoma Cells. Biomedicines 2020, 8 (12) , 595.
    29. Marcin Siwek, Anna J. Krupa, Anna Wasik. Lurasidone – pharmacodynamic and pharmacokinetic properties, clinical potential and interaction risk. Pharmacotherapy in Psychiatry and Neurology 2020, 36 (2) , 117-134.
    30. Lanchang Gao, Zhengge Yang, Jiaying Xiong, Chao Hao, Ru Ma, Xin Liu, Bi-Feng Liu, Jian Jin, Guisen Zhang, Yin Chen. Design, Synthesis and Biological Investigation of Flavone Derivatives as Potential Multi-Receptor Atypical Antipsychotics. Molecules 2020, 25 (18) , 4107.
    31. Timothy K. Beng, Victoria Shearer, Rachel Davey, Ivianne Redman. Site-selective, catalytic, and diastereoselective sp 3 C–H hydroxylation and alkoxylation of vicinally functionalized lactams. RSC Advances 2020, 10 (34) , 20264-20271.
    32. Chen Zhu, Xinwei Li, Bangyi Zhao, Weiqing Peng, Wei Li, Wei Fu. Discovery of aryl-piperidine derivatives as potential antipsychotic agents using molecular hybridization strategy. European Journal of Medicinal Chemistry 2020, 193 , 112214.
    33. Kristen Ward, Leslie Citrome. The treatment of acute agitation associated with schizophrenia or bipolar disorder: investigational drugs in early stages of their clinical development, and their clinical context and potential place in therapy. Expert Opinion on Investigational Drugs 2020, 29 (3) , 245-257.
    34. Alessandro Parisi, Maria Vittoria Pensieri, Alessio Cortellini, Carla D’Orazio, Corrado Ficorella, Lucilla Verna, Giampiero Porzio. Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series. Journal of Addictive Diseases 2020, 38 (2) , 229-234.
    35. Alessandro Passera, Antonio Mezzetti. Retracted: The Manganese(I)‐Catalyzed Asymmetric Transfer Hydrogenation of Ketones: Disclosing the Macrocylic Privilege. Angewandte Chemie 2020, 132 (1) , 193-197.
    36. Alessandro Passera, Antonio Mezzetti. Retracted: The Manganese(I)‐Catalyzed Asymmetric Transfer Hydrogenation of Ketones: Disclosing the Macrocylic Privilege. Angewandte Chemie International Edition 2020, 59 (1) , 187-191.
    37. Ana Martínez, Ilich A. Ibarra, Rubicelia Vargas, . A quantum chemical approach representing a new perspective concerning agonist and antagonist drugs in the context of schizophrenia and Parkinson’s disease. PLOS ONE 2019, 14 (12) , e0224691.
    38. Yiliang Wang, Jiaoyan Jia, Yun Wang, Feng Li, Xiaowei Song, Shurong Qin, Zhaoyang Wang, Kaio Kitazato, Yifei Wang. Roles of HSV-1 infection-induced microglial immune responses in CNS diseases: friends or foes?. Critical Reviews in Microbiology 2019, 45 (5-6) , 581-594.
    39. Konstantin A. Demin, Darya A. Meshalkina, Andrey D. Volgin, Oleg V. Yakovlev, Murilo S. de Abreu, Polina A. Alekseeva, Ashton J. Friend, Anton M. Lakstygal, Konstantin Zabegalov, Tamara G. Amstislavskaya, Tatyana Strekalova, Wandong Bao, Allan V. Kalueff. Developing zebrafish experimental animal models relevant to schizophrenia. Neuroscience & Biobehavioral Reviews 2019, 105 , 126-133.
    40. Remi Yokoi, Miho Okabe, Naoki Matsuda, Aoi Odawara, Akihiro Karashima, Ikuro Suzuki. Impact of Sleep–Wake-Associated Neuromodulators and Repetitive Low-Frequency Stimulation on Human iPSC-Derived Neurons. Frontiers in Neuroscience 2019, 13
    41. Barbara A. Bricker, Kwame Peprah, Hye J. Kang, S.Y. Ablordeppey. Evaluation of SYA16263 as a new potential antipsychotic agent without catalepsy. Pharmacology Biochemistry and Behavior 2019, 179 , 55-62.
    42. Chunxiao Qi, Xiaoming Ji, Guoliang Zhang, Yunxiao Kang, Yuanxiang Huang, Rui Cui, Shuangcheng Li, Huixian Cui, Geming Shi. Haloperidol ameliorates androgen-induced behavioral deficits in developing male rats. Journal of Endocrinology 2018, 237 (2) , 193-205.
    43. Rebecca L. Kow, Carl Sikkema, Jeanna M. Wheeler, Charles W. Wilkinson, Brian C. Kraemer. DOPA Decarboxylase Modulates Tau Toxicity. Biological Psychiatry 2018, 83 (5) , 438-446.
    44. Maria Azmanova, Anaïs Pitto-Barry, Nicolas P. E. Barry. Schizophrenia: synthetic strategies and recent advances in drug design. MedChemComm 2018, 9 (5) , 759-782.
    45. Maria Dichiara, Emanuele Amata, Antonio Rescifina, Orazio Prezzavento, Giuseppe Floresta, Carmela Parenti, Valeria Pittalà, Agostino Marrazzo. Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents. Future Medicinal Chemistry 2017, 9 (15) , 1749-1764.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect